Navigation Links
Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
Date:5/9/2011

t-family:Arial;font-size:8pt;">$
.62$
.59
Non-GAAP benefit from the out-license of Cloderm (e)$
.06
Adjusted Non-GAAP (Cash) earnings per share - diluted (excluding the Non-GAAP benefit from the out-license of Cloderm) (e)$
.56
Shares used in diluted per share calculation - GAAP earnings per share332,900158,387Shares used in diluted per share calculation - Adjusted Non-GAAP (Cash) earnings per share332,900159,205(a) Prior year non-GAAP adjustments have been modified to conform to the 2011 disclosure.(b) To supplement the financial measures prepared in accordance with generally accepted accounting principles (GAAP), the company uses non-GAAP financial measures that exclude certain items, such as amortization of inventory step-up, amortization of alliance product assets & pp&e step up, stock-based compensation step-up, restructuring and acquisition-related costs, acquired in-process research and development ("IPR&D"), legal settlements outside the ordinary course of business, the impact of currency fluctuations, acquisitions, amortization and other non-cash charges, amortization of deferred financing costs, debt discounts and ASC 470-20 (FSP APB 14-1) interest, loss on extinguishment of debt, (gain) loss on investments, net, and adjusts tax expense to cash taxes. Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. By disclosing non-GAAP
'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... 22, 2014  Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... Munich -based Brainlab to be the ... This agreement applies to the US ENT market; ... and all distribution outside the U.S. The system, ...
(Date:9/22/2014)... 2014  Sutro Biopharma today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Sutro has earned some careful ... as industry partners for what promises to be a ... John Carroll , editor of FierceBiotech .  ...
Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... China , announced today that it,will release its financial results for ... of the market on Monday, August 16, 2010 . The ... at 8:00 a.m. ET to review,the Company,s financial ...
... Advanced Brain Technologies today announced results demonstrating that a modified ... Down syndrome. The results of the study, conducted in Nottingham, United ... of the article scheduled to appear in the journal Music and Medicine(i). ... It ...
Cached Medicine Technology:Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 2Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 3Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 2Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 3
(Date:9/22/2014)... Alan Mozes HealthDay Reporter ... take note: Many American parents are aware of online physician-rating ... a pediatrician for their children, according to a new national ... than 1,600 parents -- further suggest that negative online ratings ... doctor has been recommended by a neighbor. Conversely, a ...
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... 22, 2014. Kessler researchers have published a pilot ... wellness program in people with multiple sclerosis (MS). ... health, perceived stress, and pain. "Development and ... living with MS: Description and outcomes" was epublished ... International Journal of MS Care (doi: ...
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Two new prescription devices ... may provide some relief for people with migraine headaches ... new study. One device -- the Cefaly -- ... -- the Cerena -- is meant to be used ... release. "Patients have been looking for alternative migraine ...
(Date:9/22/2014)... weather can occur with little warning, so it’s important to be ... Month, Amica Insurance is offering the following tips to ... , Build an emergency supply kit. It should contain first-aid ... per person per day for at least 72 hours. , ... your family knows what to do and where to go if ...
Breaking Medicine News(10 mins):Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Amica Shares Tips for National Preparedness Month 2
... UK after a successful bypass surgery in Delhi at a ... tourism.// ,Mavis Childs, 67, waited for more than two ... (NHS). But she opted for India when the operation was ... ,Childs, based in Wombourne, near Wolverhampton, says she traveled ...
... In a startling discovery, researchers have found that more ... several species that are popular pets. // , ... on Nov. 16), revealed that the symptoms like pain ... to the bacteria that thrive on bits of meat ...
... known as Kyolic may decrease the risk of heart ... to UK scientists.// ,Dr. Khalid Rhaman and colleagues ... supplementation of Kyolic brand aged garlic extract inhibits platelet ... blood clots. Clot formation inside healthy blood vessels is ...
... Another plant extract called Forskolin has been found to be ... cells in cultures and mice by up to 90 percent.// ... coleus forskohlii, a native of India that is used as ... plant in the US., ,CML, a malignant cancer of ...
... and Industry magazine says that tropical plants imported from ... and other related illnesses. // ,The Asian tiger ... this species was detected in the Netherlands leading to ... mosquitoes were detected in imported bamboo in a greenhouse ...
... some kinds of live mutated viruses can cure tumors in ... of Glasgow treated a patient with an aggressive //form of ... New Scientist reported. ,A mutation of the herpes virus ... four months to live in 1997. But, eight years later ...
Cached Medicine News:Health News:British Grandmother has timely bypass surgery in India 2Health News:More Lizards, Including Pets, Found Venomous 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: